Omabit raises $2M seed led by Bright Ventures to advance AI for scientific decision-making in drug development.
PRIVATEOct 27, 2026
Amount Raised
$2 Million
Round Type
Seed
San FranciscoBiotechnologyHealth CareArtificial IntelligenceMedicalPharmaceutical
Investors
Bright Ventures
Description
Omabit has successfully raised $2M in seed financing. The funding, led by Bright Ventures, will be used to enhance AI-driven scientific decision-making in the drug development process. This financing represents a significant step forward for the company. With this capital, Omabit aims to innovate and improve drug development methodologies.
Who to call at Omabit, and when
A new round usually means Omabit is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Omabit raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Omabit, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Omabit. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Omabit
Location
San Francisco, California, United States
About
Omabit is focused on leveraging AI to enhance scientific decision-making processes in the drug development sector. Their innovative approach aims to improve efficiency and outcomes in pharmaceutical research. The company is at the forefront of integrating advanced technologies into healthcare solutions.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Omabit raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.